News about Biotechnology

Samsung Bioepis Partners with Sandoz for Next-Gen Biosimilar Candidates

Samsung Bioepis has partnered with Sandoz to develop and commercialise up to five biosimilar candidates, including SB36 (vedolizumab), across global markets, excluding select Asian regions, strengthening its pipeline in immunology and oncology.

Biotechnology | 19/03/2026 | By News Bureau |  109

Aplagon Doses First Patient in Phase IIa Trial of APAC for Chronic Limb-Threatening Ischemia

Aplagon has dosed the first patient in its Phase IIa HEALING trial evaluating APAC therapy for Chronic Limb?Threatening Ischemia caused by Peripheral Arterial Occlusive Disease in Finland.

Biotechnology | 16/03/2026 | By News Bureau |  126

WHO Unveils Three Product Profiles For Next-Generation Antibiotics

The World Health Organization has released three new Target Product Profiles (TPPs) aimed at guiding the development of antibacterial medicines to combat drug-resistant bacteria responsible for severe infections such as bloodstream infections, pneumonia, urinary tract infections and meningitis.

Biotechnology | 12/03/2026 | By Darshana |  244

National Institute for Health and Care Research Launches First Tessa Jowell AHP Research Fellowships for Brain Tumour Care

National Institute for Health and Care Research announces first Tessa Jowell AHP Research Fellows to advance neuro-oncology research, addressing rehabilitation and supportive care gaps for brain tumour patients across the United Kingdom.

Biotechnology | 10/03/2026 | By News Bureau

PureHealth Research Launches Botanical GLP-1 Supplements to Support Natural Metabolic Health

PureHealth Research introduces a new range of plant-based GLP-1 supplements formulated with clinically studied botanicals to naturally support satiety signaling, metabolic wellness, and healthy blood sugar levels.

Biotechnology | 09/03/2026 | By News Bureau |  168

Biologos Appoints Hetal Patel as Chief Executive Officer

Biologos, a leading ISO 13485–certified and GMP-compliant manufacturer of custom sterile-filtered liquid solutions, announced the appointment of Hetal Patel as chief executive officer.

Biotechnology | 07/03/2026 | By Darshana |  143

Antengene Licenses ATG-201 to UCB in Deal Worth Up to USD 1.1 Billion for Autoimmune Disease Therapy

Antengene grants UCB exclusive global rights to develop and commercialise ATG-201, a CD19/CD3 bispecific T-cell engager targeting autoimmune diseases, in a deal worth over USD 1.1 billion in milestones and royalties.

Biotechnology | 06/03/2026 | By News Bureau |  170

South Africa pushes for local manufacturing of Gilead's HIV prevention drug

Gilead Sciences’ long-acting HIV prevention drug, lenacapavir, could soon be produced in South Africa as the government pushes to expand regional manufacturing and improve access to the therapy.

Biotechnology | 05/03/2026 | By Darshana |  136

YD Bio USA to Serve as Exclusive US Agent for YC Biotech's FDA Submissions

YD Bio Limited has announced that its subsidiary, YD Bio USA, Inc., has entered into a master strategic alliance agreement with YC Biotech Co Ltd to establish a cross-border regulatory platform focused on US Food and Drug Administration (FDA) submissions.

Biotechnology | 01/03/2026 | By Darshana |  136

GSK's Linerixibat Granted Priority Review in China for Cholestatic Pruritus in PBC

China’s drug regulator has accepted GSK’s linerixibat for priority review to treat cholestatic pruritus in primary biliary cholangitis, supported by Phase III data showing significant and sustained itch relief.

Biotechnology | 27/02/2026 | By News Bureau |  187